Real-World Outcomes with the KEYNOTE-522 Regimen in Early-Stage Triple-Negative Breast Cancer.
Connors C, Valente SA, ElSherif A, Escobar P, Chichura A, Kopicky L, Roesch E, Ritner J, McIntire P, Wu Y, Tu C, Lang JE.
Connors C, et al. Among authors: chichura a.
Ann Surg Oncol. 2024 Oct 22. doi: 10.1245/s10434-024-16390-7. Online ahead of print.
Ann Surg Oncol. 2024.
PMID: 39436619